Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 05 - 26 crawled time : 00:00 save search
Xencor Reports Initial Dose-Escalation Data from Phase 1 Study of XmAb®104, PD-1 x ICOS Bispecific Antibody, in Advanced Solid Tumors
Published: 2022-05-26 (Crawled : 00:00) - biospace.com/
XNCR | $18.98 -0.47% -0.47% 470K
|
Health Technology
|
| O: -0.33%
H: 0.0%
C: 0.0%
xmab antibody phase 1
Protagonist Therapeutics to Present Updated Phase 2 Rusfertide Clinical Results in Polycythemia Vera (PV) at ASCO 2022
Published: 2022-05-26 (Crawled : 00:00) - biospace.com/
PTGX | $25.23 -1.33% -1.35% 390K
|
Health Technology
|
| O: 0.13%
H: 0.0%
C: 0.0%
therapeutics asco results phase 2
Veracyte Announces New Data to be Presented at ASCO 2022 Showing Immunoscore IC Assay’s Ability to Identify Patients with NSCLC Who May Benefit from Immune Checkpoint Inhibitors
Published: 2022-05-26 (Crawled : 00:00) - biospace.com/
VCYT | $19.23 1.96% 1.92% 810K
|
Health Technology
|
| O: -1.23%
H: 0.0%
C: 0.0%
NSTG | $0.1053 -37.43% -0.19% 0
|
Health Technology
|
| O: -1.52%
H: 0.0%
C: 0.0%
asco
Exelixis Announces Detailed Results from Urothelial Carcinoma and Non-Small Cell Lung Cancer Cohorts of the COSMIC-021 Trial at ASCO 2022
Published: 2022-05-26 (Crawled : 00:00) - biospace.com/
TAK | News | $13.16 0.08% 0.0% 1.3M
|
Health Technology
|
| O: -0.17%
H: 0.0%
C: 0.0%
EXEL | $22.47 -1.75% -1.78% 2.6M
|
Health Technology
|
| O: 0.11%
H: 0.0%
C: 0.0%
osmic-021 trial asco results cancer urothelial carcinoma
Clinical Data Demonstrating Promising Antitumor Activity with Zanidatamab in 1L Setting of HER2‑Positive Breast and Gastroesophageal Cancers to be Presented at ASCO 2022
Published: 2022-05-26 (Crawled : 00:00) - biospace.com/
ZYME | $8.68 -1.92% -1.96% 730K
|
Health Technology
|
| O: 1.18%
H: 0.0%
C: 0.0%
asco her2- her2
Karyopharm to Present New Selinexor Data at the 2022 American Society of Clinical Oncology Annual Meeting
Published: 2022-05-26 (Crawled : 00:00) - biospace.com/
KPTI | $1.265 -8.33% -9.09% 1.3M
|
Health Technology
|
| O: 1.25%
H: 0.0%
C: 0.0%
Immuneering Reports Data in Two Preclinical Abstracts at the ASCO 2022 Annual Meeting Highlighting Pan-KRAS/NRAS Activity of IMM-1-104
Published: 2022-05-26 (Crawled : 00:00) - biospace.com/
IMRX | $1.77 -4.84% -5.08% 180K
|
|
| O: -1.41%
H: 0.0%
C: 0.0%
preclinical asco pre-clinical
Momelotinib Pivotal Phase 3 Data Receives Oral Presentation at American Society of Clinical Oncology Annual Meeting
Published: 2022-05-26 (Crawled : 00:00) - biospace.com/
SRRA | $54.99 0.04% 0.0%
|
Health Technology
|
| O: 0.05%
H: 0.0%
C: 0.0%
presentation phase 3
Aravive Presents Updated Clinical Data at ASCO Showing Continued Best-in-Class Potential of Batiraxcept in Advanced or Metastatic clear cell Renal Cell Carcinoma (ccRCC)
Published: 2022-05-26 (Crawled : 00:00) - biospace.com/
ARAV | $0.0401 4.74% 4M
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
renal asco potential cell carcinoma
eFFECTOR Therapeutics to Present Interim Data from Ongoing Zotatifin Phase 1/2 Dose Escalation and Expansion Trial at 2022 ASCO Annual Meeting
Published: 2022-05-26 (Crawled : 00:00) - biospace.com/
EFTR | $1.775 -6.09% -6.48% 140K
|
|
| O: -1.05%
H: 0.0%
C: 0.0%
ongoing expansion trial therapeutics asco phase 1
HOOKIPA to Present Complete HB-200 Phase 1 Results and Recommended Phase 2 Dose for HB-202/HB-201 for the Treatment of Advanced HPV16+ Cancers at ASCO
Published: 2022-05-26 (Crawled : 00:00) - biospace.com/
HOOK | $0.7695 0.92% 0.91% 170K
|
Health Technology
|
| O: 1.96%
H: 0.0%
C: 0.0%
hb-200 treatment asco phase 1 phase 2
Oncternal Therapeutics Presents Updated Interim Data for Zilovertamab in Combination with Ibrutinib at ASCO 2022
Published: 2022-05-26 (Crawled : 00:00) - biospace.com/
ONCT | News | $8.79 -1.79% -1.82% 2.8K
|
Health Technology
|
| O: -1.65%
H: 0.0%
C: 0.0%
therapeutics asco
Brookdale to Present at the Jefferies Healthcare Conference
Published: 2022-05-26 (Crawled : 00:00) - prnewswire.com
BKD | $6.52 0.93% 0.0% 1.4M
|
Health Services
|
| O: 0.8%
H: 1.58%
C: 1.58%
conference
Advanced Predictive Analytics Software Market Size to Grow by USD 9.35 billion | Find Future Trends, Analysis, and Insights | Technavio
Published: 2022-05-26 (Crawled : 00:00) - prnewswire.com
SAPGF | News | $176.75 -19.46% 1.1K
|
Technology Services
|
| O: 2.38%
H: 0.95%
C: 0.95%
SAP | News | $178.64 -0.72% 0.0% 1.5M
|
Technology Services
|
| O: 3.16%
H: 0.0%
C: 0.0%
GIB | $103.9 -0.57% 0.0% 130K
|
Technology Services
|
| O: 1.43%
H: 0.0%
C: 0.0%
analytics software market
Bionano Announces Glass Lewis Recommendation and Encourages Stockholders to Cast their Vote Ahead of June 9th Annual Meeting
Published: 2022-05-26 (Crawled : 00:00) - globenewswire.com
BNGO | $0.7801 -4.38% -4.58% 2.4M
|
Health Technology
|
| O: 2.68%
H: 14.38%
C: 14.38%
glass
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.